Ashley Stines
Family · Tuscaloosa, ALNPI 1497373328
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (49.0%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Gilead accounts for 87.7% of it on its own, with 14 other manufacturers making up the rest. 2025 is the largest year on record at $14,071, more than ten times the $115 reported in 2021. Among family clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 238 payments — averaging $122.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$26K
- Viiv Healthcare Company$2K
- Johnson & Johnson$263
- Janssen Products, LP$222
- Merck$169
- AbbVie$126
- plus $385 from 9 others
What the payments were for
- Consulting fees$1,5705%
- Speaking & faculty fees$14,24549%
- Travel & lodging$6,61023%
- Food & beverage$6,53822%
- Education$1270%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 106 | $25,526 |
| Viiv Healthcare Company | 92 | $2,400 |
| Johnson & Johnson(2 entities) | 16 | $263 |
| Janssen Products, LP | 2 | $222 |
| Merck | 6 | $169 |
| AbbVie | 2 | $126 |
| Lilly USA, LLC | 2 | $101 |
| Janssen Scientific Affairs, LLC | 1 | $63 |
| Novo Nordisk | 3 | $56 |
| Exact Sciences | 2 | $35 |
| Sanofi Pasteur Inc. | 1 | $34 |
| Shield Therapeutics Inc | 1 | $34 |
| Corcept Therapeutics | 2 | $32 |
| GSK | 1 | $16 |
| Dexcom, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$29,090 in reported general payments places this provider in the 95th percentile of 3,415 family providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 309 | $1,202,808 |
| DescovyEmtricitabine/Tenofov Alafenam | 131 | $292,698 |
| OdefseyEmtricitab/Rilpiviri/Tenof Ala | 77 | $275,198 |
| GenvoyaElviteg/Cob/Emtri/Tenof Alafen | 60 | $243,586 |
| JulucaDolutegravir/Rilpivirine | 70 | $243,208 |
| SymtuzaDarunavir/Cob/Emtri/Tenof Alaf | 51 | $235,582 |
| DovatoDolutegravir Sodium/Lamivudine | 51 | $147,868 |
| TivicayDolutegravir Sodium | 58 | $126,943 |
| PrezcobixDarunavir/Cobicistat | 22 | $51,264 |
| Darunavir | 50 | $49,314 |
| MounjaroTirzepatide | 26 | $34,555 |
| IsentressRaltegravir Potassium | 16 | $31,481 |
| TrulicityDulaglutide | 13 | $31,417 |
| JanuviaSitagliptin Phosphate | 35 | $24,582 |
| EliquisApixaban | 13 | $13,929 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy, Descovy, Genvoya | $25,526 | $1,739,093500 claims |
| Viiv Healthcare CompanyJuluca, Dovato, Tivicay | $2,400 | $518,019179 claims |
| Janssen Products, LPSymtuza | $222 | $235,58251 claims |
| Lilly USA, LLCMounjaro, Trulicity | $101 | $65,97239 claims |
| MerckIsentress, Januvia | $169 | $56,06351 claims |
| Johnson & JohnsonPrezcobix | $263 | $51,26422 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,415 family providers in Alabama.
Other family in Tuscaloosa
- Justin SimpsonTuscaloosa$43K
- Lauren KyzarTuscaloosa$17K
- Dee GuyTuscaloosa$14K
- Haley TippsTuscaloosa$14K
- Jeremy KelleyTuscaloosa$13K
- Leigh Ann ChildressHuntsville$240K
- Molly ReevesAuburn$158K
- Christina CanteyHuntsville$118K
- Leigh LunaMontgomery$69K
- Christopher LovellMobile$64K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.